עמוד 1 מ 16 תוצאות
BACKGROUND OF THE INVENTION
The invention relates generally to bicyclic carbohydrate compounds useful in the treatment of infections caused by Flaviviridae sp. and, more specifically, to such compounds useful in the treatment or amelioration of infections caused by hepatitis C, bovine viral
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/JP2017/021424, filed Jun. 9, 2017, claiming priority based on Japanese Patent Application No. 2016-120988, filed Jun. 17, 2016.
TECHNICAL FIELD
The present invention relates to a
TECHNICAL FIELD
The present invention relates generally to a method of preventing diarrhea associated with infectious agents such as rotavirus, or diarrhea associated with antibiotic therapies. More specifically, this invention relates to a powdered infant nutritional that contains the probiotic
TECHNICAL FIELD
This invention relates to the treatment or prophylaxis of conditions resulting from the accumulation of acid in the gastrointestinal tract of a human or an animal, said accumulation resulting from the fermentation of carbohydrate in the gastrointestinal tract of the human or animal.
FIELD OF THE INVENTION
The invention relates to an improved enteral nutritional formula and more particularly to infant formulas which contain ribo-nucleotide equivalents at a level of at least 10 mg/100 Kcal of formula and wherein the ribo-nucleotide components are at specific ratios.
BACKGROUND OF
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to methods and compositions for maintaining and improving gastrointestinal health and particularly to using novel food compositions for maintaining and improving gastrointestinal health.
2. Description of the
FIELD OF THE INVENTION
The invention relates to an improved enteral nutritional formula and more particularly to infant formulas which contain ribo-nucleotide equivalents at a level of at least 10 mg/100 Kcal of formula and wherein the ribo-nucleotide components are at specific ratios.
BACKGROUND OF
BACKGROUND OF THE INVENTION
1.Field of the Invention
The present invention relates to a new liquid composition, a method for producing this composition and the use of this composition as rehydration drink.
2.Description of the Related Art
There are a number of liquid compositions or diluted mixtures
This invention relates to methods and compositions for treating diarrhea.
More particularly, the invention relates to a process which effectively replaces fluid lost by a child in stools due to diarrhea and which effectively decreases stool volume.
Chronic diarrhea, and the dehydration,
FIELD OF THE INVENTION
The present invention relates to the stimulation of health in infants receiving an amino acid based formula.
BACKGROUND OF THE INVENTION
In a preferred situation, infants are breastfed by the mother. However, often in infants, after an initial period of being breast fed,
This application claims benefit of international application PCT/GB94/00713, filed Nov. 17, 1994, published as WO95/13801 May 26, 1995.
FIELD OF THE INVENTION
This invention relates to an agent for use in food, dietary, and the like preparations, and to preparations, formulations and dietary
FIELD OF THE INVENTION
The invention relates to the field of carbohydrate binding proteins, and more specifically a protein which binds specifically to particular oligosaccharides associated with particular medical significance.
BACKGROUND
The Ga1.alpha.1,3Ga1 epitope has received considerable
FIELD OF THE INVENTION
The invention relates to an improved enteral nutritional formula and more particularly to infant formulas which contain ribo-nucleotide equivalents at a level of as least 10 mg/100 Kcal of formula and wherein the ribo-nucleotide components are at specific ratios.
BACKGROUND OF
FIELD OF THE INVENTION
The invention relates to an improved enteral nutritional formula and more particularly to infant formulas which contain ribo-nucleotide equivalents at a level of at least 10 mg/100 Kcal of formula and wherein the ribo-nucleotide components are at specific ratios.
BACKGROUND OF
The present invention relates to a method of treating a mammalian creature, preferably a human, having ulcerative colitis or inflammation of the colon.
The term "Inflammatory Bowel Disease" is a designation commonly used for two related, but distinct, chronic inflammatory conditions affecting the